ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2023
An Automated Pipeline for Differential Cell Counts on Whole-Slide Bone Marrow Aspirate Smears.
Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 21 citations in OpenAlex.
- Assessment of the Performance of Siemens Scopio Digital Morphology on Bone Marrow Aspirates in Onco-Hematology.International journal of laboratory hematology · 2026Article
- Next Generation Digital Morphology: Blast Preclassification in Bone Marrow Aspirates.International journal of laboratory hematology · 2026Review
- An AI-powered self-driving microscope for low-cost acute leukemia detection.Nature communications · 2026Article
- Hematopathology Practice in the Digital Era: What has Changed?International journal of laboratory hematology · 2026Review
- Research on lung nodule detection in X-ray plain films based on improved YOLOv12 model.Scientific reports · 2026Article
- Advancements in bone marrow biopsy: the role of omics and artificial intelligence in hematologic diagnostics.Frontiers in medicine · 2026Review
- Smart FL: meta-learning for federated blood marrow smear classification.Frontiers in oncology · 2026Article
- Deep learning in bone marrow cytomorphology: advances in segmentation, classification, and clinical translation.Medical oncology (Northwood, London, England) · 2025Review
- Real-World Application of Digital Morphology Analyzers: Practical Issues and Challenges in Clinical Laboratories.Diagnostics (Basel, Switzerland) · 2025Review
- VFM-SSL-BMADCC-Framework: vision foundation model and self-supervised learning based automated framework for differential cell counts on whole-slide bone marrow aspirate smears.Frontiers in medicine · 2025Article
- Models for the marrow: A comprehensive review of AI-based cell classification methods and malignancy detection in bone marrow aspirate smears.HemaSphere · 2024Review
- Engineered feature embeddings meet deep learning: A novel strategy to improve bone marrow cell classification and model transparency.Journal of pathology informatics · 2024Article
- Deep Learning in Hematology: From Molecules to Patients.Clinical hematology international · 2024Review
- DeepHeme: A generalizable, bone marrow classifier with hematopathologist-level performance.bioRxiv : the preprint server for biology · 2023Article
- Cell projection plots: A novel visualization of bone marrow aspirate cytology.Journal of pathology informatics · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 2 institutions in 2 countries.
Funding
Abstract
The pathologic diagnosis of bone marrow disorders relies in part on the microscopic analysis of bone marrow aspirate (BMA) smears and the manual counting of marrow nucleated cells to obtain a differential cell count (DCC). This manual process has significant limitations, including the analysis of only a small subset of optimal slide areas and nucleated cells, as well as interobserver variability due to differences in cell selection and classification. To address these shortcomings, we developed an automated machine learning-based pipeline for obtaining 11-component DCCs on whole-slide BMAs. This pipeline uses a sequential process of identifying optimal BMA regions with high proportions of marrow nucleated cells, detecting individual cells within these optimal areas, and classifying these cells into 1 of 11 DCC components. Convolutional neural network models were trained on 396,048 BMA region, 28,914 cell boundary, and 1,510,976 cell class images from manual annotations. The resulting automated pipeline produced 11-component DCCs that demonstrated a high statistical and diagnostic concordance with manual DCCs among a heterogeneous group of testing BMA slides with varying pathologies and cellularities. Additionally, we demonstrated that an automated analysis can reduce the intraslide variance in DCCs by analyzing the whole slide and marrow nucleated cells within all optimal regions. Finally, the pipeline outputs of region classification, cell detection, and cell classification can be visualized using whole-slide image analysis software. This study demonstrates the feasibility of a fully automated pipeline for generating DCCs on scanned whole-slide BMA images, with the potential for improving the current standard of practice for utilizing BMA smears in the laboratory analysis of hematologic disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.